» Articles » PMID: 39263216

Combination of a Rapid Diagnostic Assay and Antimicrobial Stewardship Intervention for Gram-Negative Bacteremia

Abstract

Background: Traditional blood cultures for gram-negative bacteremia can take up to 72 hours or more to return results, prolonging the duration of empiric broad-spectrum intravenous antibiotics. The Accelerate Pheno system provides rapid identification and susceptibilities for blood cultures in gram-negative bacteremia. Current data on its clinical utility are mixed overall, so the system requires further research.

Methods: A multicenter, retrospective quasi-experimental study was conducted comparing the Accelerate Pheno rapid diagnostic system with antimicrobial stewardship intervention and traditional blood cultures alone.

Results: A total of 264 patients with blood cultures with gram-negative bacteria growth were included in the final analysis (102 pre-intervention, 162 post-intervention). The antimicrobial stewardship team made 364 recommendations in 152/162 (93.8%) patients in the post group. Duration of intravenous therapy was shorter ( < .001) for the post-intervention group (median, 4.0 days) compared with the pre-intervention group (median, 7.5 days). Hospital length of stay was also shorter ( < .001) for the post-intervention group (median, 5.1 days) compared with the pre-intervention group (median, 7.0 days). Readmission rates within 30 days were reduced ( = .042) post-intervention (13.0%) compared with pre-intervention (22.6%). In the post-intervention group, a larger proportion of patients were transitioned to oral therapy at any point (126/162, 77.8%) compared with pre-intervention (62/102, 60.8%; < .001).

Conclusions: These results suggest that the Accelerate Pheno system, with active review and intervention by a multidisciplinary antimicrobial stewardship team, is a useful tool in improving both patient-centric and antimicrobial stewardship outcomes.

Citing Articles

Rapid Blood Culture Diagnostics for Ambulatory Management of Uncomplicated Gram-Negative Bloodstream Infections.

Boda M, Rokas K, Yen C, Diekema D, Mercuro N Open Forum Infect Dis. 2025; 12(3):ofaf075.

PMID: 40046882 PMC: 11879524. DOI: 10.1093/ofid/ofaf075.

References
1.
Descours G, Desmurs L, Hoang T, Ibranosyan M, Baume M, Ranc A . Evaluation of the Accelerate Pheno™ system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections. Eur J Clin Microbiol Infect Dis. 2018; 37(8):1573-1583. DOI: 10.1007/s10096-018-3287-6. View

2.
Leligdowicz A, Dodek P, Norena M, Wong H, Kumar A, Kumar A . Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med. 2014; 189(10):1204-13. DOI: 10.1164/rccm.201310-1875OC. View

3.
Cenci E, Paggi R, De Socio G, Bozza S, Camilloni B, Pietrella D . Accelerate Pheno™ blood culture detection system: a literature review. Future Microbiol. 2020; 15:1595-1605. DOI: 10.2217/fmb-2020-0177. View

4.
. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325):629-655. PMC: 8841637. DOI: 10.1016/S0140-6736(21)02724-0. View

5.
Truong T, Mongkolrattanothai K, Flores I, Bard J . Evaluation of the Performance and Clinical Impact of a Rapid Phenotypic Susceptibility Testing Method Directly from Positive Blood Culture at a Pediatric Hospital. J Clin Microbiol. 2022; 60(8):e0012222. PMC: 9383260. DOI: 10.1128/jcm.00122-22. View